New trends in glioma cancer therapy: Targeting Na+ /H + exchangers

J Cell Physiol. 2020 Feb;235(2):658-665. doi: 10.1002/jcp.29014. Epub 2019 Jun 27.

Abstract

Glioma is the oneof the most prevalent primarybrain tumors. There is a variety of oxidative stresses, inflammatory pathways, apoptosis signaling, and Na+ /H + exchangers (NHEs) involved in the pathophysiology of glioma. Previous studies have indicated a relationship between NHEs and some molecular pathways in glioma. NHEs, including NHE1, NHE5, and NHE9 affect apoptosis, tumor-associated macrophage inflammatory pathways, matrix metalloproteinases, cancer-cell growth, invasion, and migration of glioma. Also, inhibition of NHEs contributes to increased survival in animal models of glioma. Limited studies, however, have assessed the relationship between NHEs and molecular pathways in glioma. This review summarizes current knowledge and evidence regarding the relationship between NHEs and glioma, and the mechanisms involved.

Keywords: Na+/H + exchangers; apoptosis; glioma; inflammation; matrix metalloproteinases.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Cell Proliferation / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Expression Regulation, Neoplastic / physiology
  • Glioma / drug therapy*
  • Glioma / metabolism
  • Humans
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Sodium-Hydrogen Exchangers / antagonists & inhibitors*
  • Sodium-Hydrogen Exchangers / genetics
  • Sodium-Hydrogen Exchangers / metabolism*

Substances

  • Antineoplastic Agents
  • RNA, Messenger
  • Sodium-Hydrogen Exchangers